CMC(SH:603122) Xin Lang Cai Jing·2025-10-31 11:06Core Viewpoint - The stock price of the company has experienced a significant increase, with a cumulative rise of over 20% in two consecutive trading days, indicating abnormal trading fluctuations. However, the company has confirmed that there are no undisclosed major issues affecting its performance [1] Group 1: Company Performance - The company has reported a decline in performance, resulting in losses primarily due to changes in the domestic macroeconomic environment and adjustments in healthcare industry policies [1] - The recent surge in the company's stock price may be attributed to irrational speculation, raising concerns about potential volatility [1] Group 2: Investor Advisory - The company advises investors to be cautious regarding performance fluctuations and to avoid being influenced by overly optimistic market sentiments, emphasizing the importance of recognizing trading risks [1]